Maggie L Wong

Maggie Wong is a partner in Goodwin’s nationally recognized Life Sciences group. She represents private and public companies in the biotechnology, pharmaceutical, digital health and medical technology industries, serving as a legal and business adviser across their entire corporate lifecycle. Maggie provides strategic and legal advice to clients as they develop, in-license and acquire intellectual property and other assets, raise capital to fund their operations, execute on strategic alliances and engage in exit transactions. Maggie regularly counsels clients on pre-incorporation planning, seed, venture and late-stage private financings, IPOs and other capital markets transactions, SEC compliance, corporate governance, and mergers and acquisitions. She also has substantial experience advising on licensing, collaboration, partnering, distribution, and other commercial agreements.

Maggie is a member of Goodwin’s Partnership Committee and Opinions Committee. Maggie is also a member of Goodwin’s PropSci practice which is focused on supporting the intersection of real estate and life sciences through thoughtful collaboration across the two practice areas.